FDA rejects Zealand Pharma’s short bowel syndrome drug

The FDA re­ject­ed Zealand Phar­ma’s short bow­el syn­drome drug, and asked the com­pa­ny to run an­oth­er tri­al be­fore it re­con­sid­ers.

The FDA told Zealand it …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.